Diabetes Mellitus, Type 2 Clinical Trials
58 studies are recruiting for diabetes mellitus, type 2 in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
By city
Studies, page 2
-
Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)
Sixteen institutions will be selected from a HRSA uniform data system and have data collected for up to 3 years. Eight institutions will begin the iPATH practice transformation during year one, the other eight institutions will begin iPATH in year two. FQHC administrators, clinicians and staff will…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Board of Trustees of the Leland Stanford Junior University, Stanford, California
- Locations
- 4 in total
- Run by
- Stanford University
-
Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature
A prospective, multicenter evaluation of performance and safety of the Eversense Gemini System with flash glucose measurement feature. The purpose of this clinical investigation is to evaluate the accuracy of the Gemini System with new technological flash glucose monitoring (FGM) feature enhancemen…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Headlands Research - AMCR Institute, Escondido, California
- Run by
- Senseonics, Inc.
-
ROME GS System Study
The purpose of this clinical investigation is to demonstrate that the proposed physical changes to the ROME GS Sensor do not have any adverse impact on safety and performance when compared to the Eversense 365 Sensor.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Headlands Research - AMCR Institute, Escondido, California
- Locations
- 4 in total
- Run by
- Senseonics, Inc.
-
Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide
This study is to investigate how adipocyte (fat cell) function and fat distribution differ between individuals with normal-weight type 2 diabetes (NWD), those with overweight type 2 diabetes (OWD), and normal-weight controls without diabetes (NWC). The study will assess whether adipocyte-directed t…
- Stage
- Phase 4
- Ages
- 30 to 70
- Site
- Stanford University, Palo Alto, California
- Locations
- 2 in total
- Run by
- Stanford University
-
Boosting Emotional Well-being and Happiness in Outpatients Living With Diabetes
The focus of this study is to test the efficacy of an 8-week, remotely delivered, positive-psychology-motivational interviewing (PP-MI) intervention, with additional twice weekly text messages for a total of 16 weeks (with interactive, algorithm-driven, goal-focused text messages in the final 8 wee…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Massachusetts General Hospital, Boston, Massachusetts
- Run by
- Massachusetts General Hospital
-
Project Dulce for Arab Americans With Type 2 Diabetes
Arab Americans (AA) face many challenges in diabetes self-management due to the limited educational resources and support available for them. The cultural and linguistic barriers between patients and health care providers lead to poor diabetes management and outcomes. This study (Project Dulce Arab…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Metro Caring, Denver, Colorado
- Locations
- 2 in total
- Run by
- Scripps Whittier Diabetes Institute
-
Transformative Research in Diabetic Nephropathy 2.0
The goal of this observational study is to learn more about kidney health in adults with diabetic kidney disease and other groups. Researchers will study kidney tissue and other samples. They want to learn how sodium-glucose cotransporter-2 (SGLT2) inhibitors, a type of diabetes medicine, may affec…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Penn Presbyterian Medical Center, Philadelphia, Pennsylvania
- Run by
- University of Pennsylvania
-
Pilot-Testing Real-Time Engagement for Learning to Effectively Control Type 2 Diabetes
The goal of this study is to pilot test features of a new smartphone app and to gather feedback related to wearing a continuous glucose monitor (CGM) and a Fitbit device, as well as to obtain input on health behavior-focused messages delivered through the app. The study will enroll English-speaking…
- Stage
- Not phased
- Ages
- 16 to 24
- Site
- Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania
- Run by
- University of Pittsburgh
-
Blood Markers of Early Pancreas Cancer
Identifying biomarkers of early pancreatic ductal adenocarcinoma (PDAC) could facilitate screening for individuals at higher than average risk and expedite the diagnosis in individuals with symptoms and substantially improve an individual's chance of surviving the disease. The investigators propose…
- Stage
- Not phased
- Ages
- 19 and older
- Site
- Unversity of Nebraska Medical Center, Omaha, Nebraska
- Run by
- University of Nebraska
-
Use of CGM in Kidney Transplant Recipients
The investigators want to study the impact CGM (continuous glucose monitoring) has on patients glycemic control as determined by time in range (TIR 70-180 mg/dL) in the Diabetic Kidney Transplant population.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- UC Davis Health, Sacramento, California
- Run by
- University of California, Davis
-
Drug Interaction Potential of Pro-Inflammatory Conditions
Pro-inflammatory cytokines, which are elevated in pro-inflammatory disease states (e.g., type II diabetes mellitus [T2DM], irritable bowel diseases [IBD], and end stage renal disease [ESRD]) have been shown to inhibit hepatic drug-metabolizing enzymes, including members of the cytochrome P450 (CYP)…
- Stage
- Not phased
- Ages
- 12 to 99
- Site
- Indiana University Hospital, Indianapolis, Indiana
- Run by
- Indiana University
-
Improving Diabetes Care With Strategies For Addressing Health-Related Social Needs and Community Partnerships
The goal of this study is to develop, implement, and evaluate a patient-centered triage and referral model designed to improve health outcomes for individuals with uncontrolled type 2 diabetes mellitus (T2DM) and unmet health-related social needs. The intervention builds on the existing THRIVE infr…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Boston Medical Center, Boston, Massachusetts
- Run by
- Boston Medical Center
-
Family Model DSME in FBOs in the RMI
Health disparities in the Republic of the Marshall Islands are striking, with extremely high rates of type 2 diabetes. Documented prevalence of type 2 diabetes in the Marshall Islands ranges from 20%-50%.This is significantly higher than the global (8.5%) and United States (11%) prevalence. Diabete…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- UAMS Institute for Community Health Innovation, Springdale, Arkansas
- Run by
- University of Arkansas
-
Post Prandial Individual Responses to Different Foods
This study aims to understand why people respond differently to the same foods, especially when it comes to changes in blood sugar after eating. A continuous glucose monitors (CGMs) will be used to observe how individuals respond to specific meals and drinks (e.g., Oral Glucose Tolerance Test, OGTT…
- Stage
- Not phased
- Ages
- 18 to 80
- Site
- Stanford University, Stanford, California
- Run by
- Stanford University
-
SCS for Patient With Painful Diabetic Neuropathy and Peripheral Arterial Disease
Peripheral arterial disease (PAD) affects over 230 million adults worldwide and is a highly morbid, costly, and disabling condition. Ischemic leg pain drives disability in PAD patients and results from oxygen supply-demand mismatch, autonomic dysfunction, and muscle breakdown. This leg pain, which …
- Stage
- Not phased
- Ages
- 19 to 89
- Site
- University of Nebraska Medical Center, Omaha, Nebraska
- Run by
- University of Nebraska
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
The purpose of this study is to determine the effectiveness of mobile health applications in improving health outcomes and the subsequent benefit of improving type II diabetes outcomes in a low socioeconomic Hispanic population. This study will involve a 6-month long commitment where participants w…
- Stage
- Not phased
- Ages
- 18 to 64
- Site
- San Diego State University, San Diego, California
- Run by
- San Diego State University
-
Efficacy of Using Mobile Health Applications for Health
The purpose of this study is to determine the effectiveness of mobile health applications in improving health outcomes and type II diabetes outcomes in type 2 diabetics. This study will involve a 6-month long commitment where participants will be expected to weigh themselves every morning, at the s…
- Stage
- Not phased
- Ages
- 18 to 64
- Site
- San Diego State University, San Diego, California
- Run by
- San Diego State University
-
MANAGe-DM: Novel Nurse Case Management to Improve Diabetes Outcomes in Formerly Incarcerated Black Men
The study is a randomized control trial involving 100 participants (formerly incarcerated Black men with poorly controlled diabetes) to examine the effect of a tailored nurse case manager on glycemic control and other clinical outcomes, self-care behaviors, and quality of life at 6 months post-rand…
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- Center for Advancing Population Science, Medical College of Wisconsin, Milwaukee, Wisconsin
- Run by
- Medical College of Wisconsin
-
Phenotyping Genetic Risk for Type 2 Diabetes
This study tests the hypothesis that non-diabetic individuals with a high genetic risk score for type 2 diabetes have impaired glucose tolerance and insulin resistance compared to those with a low genetic risk score for type 2 diabetes.
- Stage
- Not phased
- Ages
- 10 to 70
- Site
- University of Pennsylvania, Philadelphia, Pennsylvania
- Locations
- 2 in total
- Run by
- University of Pennsylvania
-
Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
HYPOTHESIS: Impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) have distinct pathophysiologic etiologies. Therefore, therapeutic interventions designed to correct the specific underlying pathogenic abnormalities in IGT and IFG will be required to optimally prevent the progressive b…
- Stage
- Not phased
- Ages
- 18 to 65
- Site
- The University of Texas Health Science Center at San Antonio, San Antonio, Texas
- Run by
- The University of Texas Health Science Center at San Antonio
-
Linking Education, Produce Provision, and Community Referrals to Improve Diabetes Care (LINK)
This is a pragmatic randomized controlled trial (pRCT) that aims to test the effect of produce provision, diabetes education, and community referrals on hemoglobin A1c levels in individuals with type 2 diabetes experiencing food insecurity.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- The Ohio State University Wexner Medical Center, Columbus, Ohio
- Run by
- Ohio State University
-
Assessing the Value of Avocados on Glycemic Control in Type 2 Diabetes
The objective of this study is to assess the effects of Hass Avocados on glycemic control. The investigators hypothesize that Hass Avocado consumption will reduce fasting blood sugar compared to an isocaloric amount of other fruit during controlled feeding.
- Stage
- Not phased
- Ages
- 18 to 65
- Site
- Pennington Biomedical Research Center, Baton Rouge, Louisiana
- Run by
- Pennington Biomedical Research Center
-
Impact of a Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes
The goal of this clinical trial is to evaluate the use and effectiveness of a mobile web application (app) that is designed to educate and allow patients to manage diabetes and make sustainable lifestyle changes, and to study the impact of the app on clinical outcomes of diabetes (HA1C) and educati…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Reading Hospital, an affiliate of Tower Health, West Reading, Pennsylvania
- Run by
- The Reading Hospital and Medical Center
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
The proposed study will use a randomized clinical trial design with non-equivalent control group and longitudinal design to evaluate the feasibility, acceptability, and preliminary effects of the Diabetes LIVE JustICE application. The design will incorporate repeated measures at 0, 6, and 12 weeks.…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Connecticut, Storrs, Connecticut
- Locations
- 2 in total
- Run by
- Louise Reagan
-
Effects of High-Resistance Inspiratory Muscle Strength Training on Cardiorenal and Vascular Function in Youth and Young Adults With Type 2 Diabetes
High-resistance, short-duration inspiratory muscle strength training (IMST) is a novel lifestyle intervention involving 30 inhalations against a resistive load which requires only ~5 min/day and is thus ideal for youth with T2D (Y-T2D). Investigators seek to 1: assess changes in casual and 24-hr SB…
- Stage
- Not phased
- Ages
- 14 to 40
- Site
- Seattle Children's Hospital, Seattle, Washington
- Locations
- 2 in total
- Run by
- Seattle Children's Hospital
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.